Stock listing
NB3 Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.
Selected listing: NB3 · BX · CHF · CH
This page tracks Neurocrine Biosciences, Inc.'s NB3:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NB3:BX. NB3:BX is the stock-level entry point for investors researching Neurocrine Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neurocrine Biosciences, Inc. (ticker: NBIX) is a public company based in America, specializing in biopharmaceuticals. With a market capitalization of approximately $17.67 billion, Neurocrine focuses on developing treatments for neurological and endocrine disorders. The company is committed to advancing innovative therapies to improve patient outcomes.
- Ticker
- NB3:BX
- Asset type
- Stock
- Market cap
- $14.86B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BX
- Currency
- CHF
Neurocrine Biosciences, Inc. NB3:BX stock context
This page tracks Neurocrine Biosciences, Inc.'s NB3:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NB3:BX. NB3:BX is the stock-level entry point for investors researching Neurocrine Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neurocrine Biosciences, Inc. (ticker: NBIX) is a public company based in America, specializing in biopharmaceuticals. With a market capitalization of approximately $17.67 billion, Neurocrine focuses on developing treatments for neurological and endocrine disorders. The company is committed to advancing innovative therapies to improve patient outcomes.
Latest news from Neurocrine Biosciences, Inc.
Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living with Tardive Dyskinesia
August 12, 2026
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist
August 7, 2026
Neurocrine Biosciences Reports Second-Quarter 2026 Financial Results
July 30, 2026
Neurocrine Biosciences Announces Key Leadership Hiring, Promotions
July 23, 2026
Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer
July 21, 2026
Neurocrine Biosciences, Inc. earnings calls
Neurocrine Biosciences, Inc. (NBIX) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Neurocrine Biosciences, Inc. (NBIX) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Neurocrine Biosciences, Inc. (NBIX) Q4 2025 Earnings Call
February 11, 2026 · Replay with transcript and chapters
Neurocrine Biosciences, Inc. (NBIX) Q3 2025 Earnings Call
October 28, 2025 · Replay with transcript and chapters
Neurocrine Biosciences, Inc. (NBIX) Q2 2025 Earnings Call
July 30, 2025 · Replay with transcript and chapters
Neurocrine Biosciences, Inc. (NBIX) Q1 2025 Earnings Call
May 5, 2025 · Replay with transcript and chapters
Research Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. investor report
Review AI stock analysis and investor report context for NB3:BX.
Neurocrine Biosciences, Inc. company profile
View the public company page for Neurocrine Biosciences, Inc. on 6ix.
Neurocrine Biosciences, Inc. news
Read company news and market updates connected to Neurocrine Biosciences, Inc..
Neurocrine Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Neurocrine Biosciences, Inc..
Alternate listings
NBIX:NASDAQ
US · USD
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
NB3:GETTEX
DE · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
900964:LS
DE · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
NB3:FWB
DE · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
900964:LSX
DE · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
NBIX:BMV
MX · MXN
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
0K6R:LSE
GB · USD
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
N1BI34:BMFBOVESPA
BR · BRL
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
NB3:TRADEGATE
DE · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
1NBIX:MIL
IT · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
NBIX:BIVA
MX · MXN
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.
NBIX:BOATS
US · USD
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is NB3:BX.